# RF Acquisition Corp II (RFAI) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare. Price $41.50, market value $346 million.

## Valuation
- **P/E (trailing): 345.8×**. RF Acquisition Corp II trades at 345.8× trailing earnings. The Healthcare median in the September 2026 study was 28.5×.
- **Earnings yield: 0.3%**. The inverse of the P/E: 0.3% of the price is earned each year.

## Profitability
- **Return on equity: -73.3%**. Return on equity is negative because earnings are negative.

## Financial health
- **Current ratio: 0.41** (quick 0.41). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.

## Dividends
- **Dividend: none**. RF Acquisition Corp II does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 291.1%** (YTD 286.0%, 3-mo 276.9%). The shares are up 291.1% over twelve months including dividends.
- **From 52-week high: -43.2%** (364.2% above the low). Trading 43% below its 52-week high, deep in a drawdown.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 64**. An RSI of 64 is neutral.
- **Beta (1 yr): 0.81** (volatility 357%). Beta of 0.81 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=RFAI · Page: https://foliofundamentals.com/stocks/rfai

Not investment advice.